Novavax Inc (NASDAQ:NVAX)

1.82
Delayed Data
As of Nov 16
 0.00 / 0.00%
Today’s Change
1.05
Today|||52-Week Range
2.75
--
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.82
Today’s open1.76
Day’s range1.75 - 1.84
Volume4,800,575
Average volume (3 months)5,337,725
Market cap$681.5M
Data as of 4:00pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)+38.83%
Earnings growth (this year)+19.29%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+103.06%
P/E ratioNM
Price/Sales11.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...0.000.00%
ANIPANI Pharmaceuticals ...0.000.00%
RDUSRadius Health Inc0.000.00%
EPZMEpizyme Inc0.000.00%
Data as of 4:00pm ET, 11/16/2018

Financials

Next reporting dateMarch 4, 2019
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$31.2M
Annual profit (last year)-$183.8M
Net profit margin-589.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts